At #ESMO26, Rahul Winayak, MD (@cityofhope) explains new metastatic #RCC targets—GPR65, HPK1, ENPP3, CD70—that aim to overcome #immunotherapy resistance.

Targeted Oncology· @TargetedOnc · X·2026-10-25 05:00· 19 hours agoScore45

Body

🎥 WATCH: https://www.targetedonc.com/view/rahul-winayak-emerging-therapeutic-targets-metastatic-renal-cell-carcinoma

#KidneyCancer #Oncology | @RWinayak @CityofHope_GU

31 views · 0 likes · 0 reposts · 0 replies

Source: Targeted Oncology · x.com